BELLI, MARTINA
BELLI, MARTINA
Dipartimento di Medicina dei sistemi
Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born?
2023-11-23 Lecis, D; Prandi, Fr; Barone, L; Belli, M; Sergi, D; Longo, S; Muscoli, S; Romeo, F; Federici, M; Lerakis, S; Barillà, F
Diagnosis of atrial cardiomyopathy: from the electrocardiogram to the new opportunities with multimodality imaging
2025-02-01 Belli, M; Margonato, D; Prandi, Fr; Barone, L; Muscoli, S; Lecis, D; Mollace, R; Sergi, D; Cavalcante, Jl; Lerakis, S; Barillà, F
Glucose variability: a new risk factor for cardiovascular disease
2023-10-01 Belli, M; Bellia, A; Sergi, D; Barone, L; Lauro, D; Barillà, F
Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
2023-07-26 Belli, M; Barone, L; Longo, S; Prandi, Fr; Lecis, D; Mollace, R; Margonato, D; Muscoli, S; Sergi, D; Federici, M; Barillà, F
The Impact of Gitelman Syndrome on Cardiovascular Disease: From Physiopathology to Clinical Management
2022-01-01 Bezzeccheri, A; Di Giovanni, G; Belli, M; Mollace, R; Barone, L; Macrini, M; Di Landro, A; Muscoli, S
Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?
2022-01-01 Belli, M; Barone, L; Bellia, A; Sergi, D; Lecis, D; Prandi, Fr; Milite, M; Galluccio, C; Muscoli, S; Romeo, F; Barillà, F
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 23-nov-2023 | Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born? | Lecis, D; Prandi, Fr; Barone, L; Belli, M; Sergi, D; Longo, S; Muscoli, S; Romeo, F; Federici, M; Lerakis, S; Barillà, F | Articolo su rivista | |
| 1-feb-2025 | Diagnosis of atrial cardiomyopathy: from the electrocardiogram to the new opportunities with multimodality imaging | Belli, M; Margonato, D; Prandi, Fr; Barone, L; Muscoli, S; Lecis, D; Mollace, R; Sergi, D; Cavalcante, Jl; Lerakis, S; Barillà, F | Articolo su rivista | |
| 1-ott-2023 | Glucose variability: a new risk factor for cardiovascular disease | Belli, M; Bellia, A; Sergi, D; Barone, L; Lauro, D; Barillà, F | Articolo su rivista | |
| 26-lug-2023 | Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target? | Belli, M; Barone, L; Longo, S; Prandi, Fr; Lecis, D; Mollace, R; Margonato, D; Muscoli, S; Sergi, D; Federici, M; Barillà, F | Articolo su rivista | |
| 1-gen-2022 | The Impact of Gitelman Syndrome on Cardiovascular Disease: From Physiopathology to Clinical Management | Bezzeccheri, A; Di Giovanni, G; Belli, M; Mollace, R; Barone, L; Macrini, M; Di Landro, A; Muscoli, S | Articolo su rivista | |
| 1-gen-2022 | Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients? | Belli, M; Barone, L; Bellia, A; Sergi, D; Lecis, D; Prandi, Fr; Milite, M; Galluccio, C; Muscoli, S; Romeo, F; Barillà, F | Articolo su rivista |